EUVIMEDEUVIMED entdecken
Open Access

Ceftaroline: A New Cephalosporin with Activity Against Methicillin-Resistant Staphylococcus aureus (MRSA)

Christopher Duplessis, Nancy F Crum-Cianflone

Clinical Medicine Reviews in Therapeutics · 2011

DOI: 10.4137/cmrt.s1637 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Medicine Reviews in Therapeutics, 2011. Verfasst von Christopher Duplessis und 1 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Disease Division, Naval Medical Center San Diego, San Diego, CA United States. Die Arbeit wurde bisher 32-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Infectious Disease Division, Naval Medical Center San Diego, San Diego, CA United States.

Förderung

  • NIAID NIH HHS

Zitieren

APA

Duplessis, C., & Crum-Cianflone, N. F. (2011). Ceftaroline: A New Cephalosporin with Activity Against Methicillin-Resistant Staphylococcus aureus (MRSA). Clinical Medicine Reviews in Therapeutics. https://doi.org/10.4137/cmrt.s1637

Vancouver

Duplessis C, Crum-Cianflone NF. Ceftaroline: A New Cephalosporin with Activity Against Methicillin-Resistant Staphylococcus aureus (MRSA). Clinical Medicine Reviews in Therapeutics. 2011. doi:10.4137/cmrt.s1637

BibTeX
@article{Duplessis2011,
  author = {Duplessis, Christopher and Crum-Cianflone, Nancy F},
  title = {Ceftaroline: A New Cephalosporin with Activity Against Methicillin-Resistant Staphylococcus aureus (MRSA)},
  journal = {Clinical Medicine Reviews in Therapeutics},
  year = {2011},
  doi = {10.4137/cmrt.s1637}
}
Kostenlos starten →